56 related articles for article (PubMed ID: 26172534)
1. Development of Pancreatic Cancer, Disease-specific Mortality, and All-Cause Mortality in Patients with Nonresected IPMNs: A Long-term Cohort Study.
Nagata N; Kawazoe A; Mishima S; Wada T; Shimbo T; Sekine K; Watanabe K; Imbe K; Kojima Y; Kumazawa K; Mihara F; Tokuhara M; Edamoto Y; Igari T; Yanase M; Mizokami M; Akiyama J; Uemura N
Radiology; 2016 Jan; 278(1):125-34. PubMed ID: 26172534
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Outcomes and Risk of Pancreatic Cancer in Intraductal Papillary Mucinous Neoplasms.
de la Fuente J; Chatterjee A; Lui J; Nehra AK; Bell MG; Lennon RJ; Kassmeyer BA; Graham RP; Nagayama H; Schulte PJ; Doering KA; Delgado AM; Vege SS; Chari ST; Takahashi N; Majumder S
JAMA Netw Open; 2023 Oct; 6(10):e2337799. PubMed ID: 37847503
[TBL] [Abstract][Full Text] [Related]
3. Incidental pancreatic cystic lesions: is there a relationship with the development of pancreatic adenocarcinoma and all-cause mortality?
Chernyak V; Flusberg M; Haramati LB; Rozenblit AM; Bellin E
Radiology; 2015 Jan; 274(1):161-9. PubMed ID: 25117591
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of a 3-Year Prospective Surveillance in Individuals at High Risk of Pancreatic Cancer.
Paiella S; Capurso G; Carrara S; Secchettin E; Casciani F; Frigerio I; Zerbi A; Archibugi L; Bonifacio C; Malleo G; Cavestro GM; Barile M; Larghi A; Assisi D; Fantin A; Milanetto AC; Fabbri C; Casadei R; Donato G; Sassatelli R; De Marchi G; Di Matteo FM; Arcangeli V; Panzuto F; Puzzono M; Dal Buono A; Pezzilli R; Salvia R; Rizzatti G; Casadio M; Franco M; Butturini G; Pasquali C; Coluccio C; Ricci C; Cicchese N; Sereni G; de Pretis N; Stigliano S; Rudnas B; Marasco M; Lionetto G; Arcidiacono PG; Terrin M; Crovetto A; Mannucci A; Laghi L; Bassi C; Falconi M
Am J Gastroenterol; 2024 Apr; 119(4):739-747. PubMed ID: 37787643
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of the IMMray PanCan-d Test in High-Risk Individuals Undergoing Pancreatic Surveillance: Pragmatic Data and Lessons Learned.
Katona BW; Worthington C; Clay D; Cincotta H; Ahmad NA; Ginsberg GG; Kochman ML; Brand RE
JCO Precis Oncol; 2023 Sep; 7():e2300445. PubMed ID: 37883920
[TBL] [Abstract][Full Text] [Related]
6. Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.
Ceppa EP; Roch AM; Cioffi JL; Sharma N; Easler JJ; DeWitt JM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
Surgery; 2015 Oct; 158(4):937-44; discussion 944-5. PubMed ID: 26173683
[TBL] [Abstract][Full Text] [Related]
7. Validation of the American Gastroenterological Association guidelines on management of intraductal papillary mucinous neoplasms: more than 5 years of follow-up.
Imbe K; Nagata N; Hisada Y; Takasaki Y; Sekine K; Mishima S; Kawazoe A; Tajima T; Shimbo T; Yanase M; Akiyama J; Fujimoto K; Uemura N
Eur Radiol; 2018 Jan; 28(1):170-178. PubMed ID: 28770404
[TBL] [Abstract][Full Text] [Related]
8. Intraductal papillary mucinous neoplasms of the pancreas and European guidelines: importance of the surgery type in the decision-making process.
Buscail E; Cauvin T; Fernandez B; Buscail C; Marty M; Lapuyade B; Subtil C; Adam JP; Vendrely V; Dabernat S; Laurent C; Chiche L
BMC Surg; 2019 Aug; 19(1):115. PubMed ID: 31438917
[TBL] [Abstract][Full Text] [Related]
9. Comparison of imaging modalities for measuring the diameter of intraductal papillary mucinous neoplasms of the pancreas.
Huynh T; Ali K; Vyas S; Dezsi K; Strickland D; Basinski T; Chen DT; Jiang K; Centeno B; Malafa M; Klapman JB; Hodul PJ; Jeong D; Permuth JB
Pancreatology; 2020 Apr; 20(3):448-453. PubMed ID: 32113936
[TBL] [Abstract][Full Text] [Related]
10. High-risk lesions in the remnant pancreas: fate of the remnant pancreas after pancreatic resection for pancreatic cancer and intraductal papillary mucinous neoplasms.
Miyasaka Y; Ohtsuka T; Matsuda R; Mori Y; Nakata K; Ohuchida K; Nakamura M
Surg Today; 2020 Aug; 50(8):832-840. PubMed ID: 31346809
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and Outcomes of Pancreatic Cancer by Histological Subtypes.
Luo G; Fan Z; Gong Y; Jin K; Yang C; Cheng H; Huang D; Ni Q; Liu C; Yu X
Pancreas; 2019 Jul; 48(6):817-822. PubMed ID: 31210663
[TBL] [Abstract][Full Text] [Related]
12. Results of First-Round of Surveillance in Individuals at High-Risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry.
Paiella S; Capurso G; Cavestro GM; Butturini G; Pezzilli R; Salvia R; Signoretti M; Crippa S; Carrara S; Frigerio I; Bassi C; Falconi M; Iannicelli E; Giardino A; Mannucci A; Laghi A; Laghi L; Frulloni L; Zerbi A
Am J Gastroenterol; 2019 Apr; 114(4):665-670. PubMed ID: 30538291
[TBL] [Abstract][Full Text] [Related]
13. ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts.
Elta GH; Enestvedt BK; Sauer BG; Lennon AM
Am J Gastroenterol; 2018 Apr; 113(4):464-479. PubMed ID: 29485131
[TBL] [Abstract][Full Text] [Related]
14. Effect of low-dose aspirin use on pancreatic cancer development and morphological changes on imaging in IPMN: A long-term cohort study.
Takasaki Y; Nagata N; Imbe K; Hisada Y; Sekine K; Tajima T; Yanase M; Fujimoto K; Akiyama J; Uemura N
United European Gastroenterol J; 2017 Nov; 5(7):1030-1036. PubMed ID: 29163970
[TBL] [Abstract][Full Text] [Related]
15. Acute Severe Gastrointestinal Tract Bleeding Is Associated With an Increased Risk of Thromboembolism and Death.
Nagata N; Sakurai T; Shimbo T; Moriyasu S; Okubo H; Watanabe K; Yokoi C; Yanase M; Akiyama J; Uemura N
Clin Gastroenterol Hepatol; 2017 Dec; 15(12):1882-1889.e1. PubMed ID: 28634133
[TBL] [Abstract][Full Text] [Related]
16. Fukuoka criteria accurately predict risk for adverse outcomes during follow-up of pancreatic cysts presumed to be intraductal papillary mucinous neoplasms.
Mukewar S; de Pretis N; Aryal-Khanal A; Ahmed N; Sah R; Enders F; Larson JJ; Levy MJ; Takahashi N; Topazian M; Pearson R; Vege SS; Chari ST
Gut; 2017 Oct; 66(10):1811-1817. PubMed ID: 27390303
[TBL] [Abstract][Full Text] [Related]
17. Early detection of pancreatic cancer in the era of precision medicine.
Ahmed TM; Kawamoto S; Lopez-Ramirez F; Yasrab M; Hruban RH; Fishman EK; Chu LC
Abdom Radiol (NY); 2024 May; ():. PubMed ID: 38761272
[TBL] [Abstract][Full Text] [Related]
18. Pre-Operative Imaging and Pathological Diagnosis of Localized High-Grade Pancreatic Intra-Epithelial Neoplasia without Invasive Carcinoma.
Sagami R; Yamao K; Nakahodo J; Minami R; Tsurusaki M; Murakami K; Amano Y
Cancers (Basel); 2021 Feb; 13(5):. PubMed ID: 33668239
[TBL] [Abstract][Full Text] [Related]
19. Side-branch intraductal papillary mucinous neoplasms of the pancreas: outcome of MR imaging surveillance over a 10 years follow-up.
Boraschi P; Tarantini G; Donati F; Scalise P; Cervelli R; Caramella D
Eur J Radiol Open; 2020; 7():100250. PubMed ID: 32884981
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of consensus guideline based management of pancreatic cysts: The sensitivity and specificity required for guidelines to be cost-effective.
Sharib J; Esserman L; Koay EJ; Maitra A; Shen Y; Kirkwood KS; Ozanne EM
Surgery; 2020 Oct; 168(4):601-609. PubMed ID: 32739138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
